$812.03M
Revenue
$-68.09M
Net Income
32.79%
Gross Margin
5.56%
Op. Margin
$66.89M
Free Cash Flow
| Breakdown | FY 2025 (Dec 31, 2025) |
|---|---|
| Total Revenue | $812.03M |
| Revenue Growth % | nan% |
| Cost of Revenue | $545.73M |
| Gross Profit | $266.30M |
| Gross Margin % | 32.8% |
| Operating Expenses | $766.92M |
| Research & Development | $101.58M |
| Operating Income | $45.11M |
| Operating Margin % | 5.6% |
| Interest Expense | $56.81M |
| Other Income/Expense | $-20.56M |
| Income Before Tax | $-68.09M |
| Net Income | $-68.09M |
| Net Margin % | -8.4% |
| Basic EPS | -3.22 |
| Diluted EPS | -3.22 |
| Basic Shares Outstanding | 167.2M |
| Diluted Shares Outstanding | 167.2M |
| Breakdown | FY 2025 (Dec 31, 2025) |
|---|---|
| Cash & Cash Equivalents | $796.27M |
| Short-term Investments | $2.29M |
| Accounts Receivable | $112.14M |
| Other Current Assets | $2.35M |
| Total Current Assets | $997.80M |
| Property Plant & Equipment | $63.17M |
| Goodwill | $19.34M |
| Other Non-current Assets | $45.35M |
| Total Assets | $1.13B |
| Accounts Payable | $39.21M |
| Accrued Liabilities | $87.77M |
| Deferred Revenue | $24.50M |
| Total Current Liabilities | $127.14M |
| Long-term Debt | $378.45M |
| Other Non-current Liabilities | $42.39M |
| Total Liabilities | $548.36M |
| Common Stock | $283.00K |
| Retained Earnings | $-2.55B |
| Total Stockholders Equity | $577.31M |
| Total Liabilities & Equity | $1.13B |
| Breakdown | FY 2025 (Dec 31, 2025) |
|---|---|
| Net Income | $-68.09M |
| Depreciation & Amortization | $22.61M |
| Stock-based Compensation | $70.01M |
| Change in Receivables | $29.79M |
| Change in Payables | $11.04M |
| Operating Cash Flow | $83.16M |
| Capital Expenditure | $16.26M |
| Investing Cash Flow | $-16.26M |
| Stock Repurchased | $113.00K |
| Financing Cash Flow | $664.99M |
| Net Change in Cash | $732.01M |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $216.83M | $101.62M | $519.15M | $282.35M |
| Operating Expenses | $184.19M | $162.46M | $562.45M | $502.42M |
| Research & Development | $21.62M | $27.64M | $69.74M | $86.81M |
| Operating Income | $32.64M | $-60.84M | $-43.30M | $-220.08M |
| Interest Expense | $13.51M | $13.80M | $45.50M | $36.76M |
| Other Income/Expense | $-89.00K | $37.00K | $-18.45M | $-323.00K |
| Income Before Tax | $24.32M | $-67.73M | $-150.04M | $-244.94M |
| Income Tax Expense | - | - | - | - |
| Net Income | $24.32M | $-67.73M | $-150.04M | $-244.94M |
| Basic EPS | 0.09 | -2.59 | -4.83 | -8.92 |
| Diluted EPS | 0.08 | -2.59 | -4.83 | -8.92 |
| Basic Shares Outstanding | $282.10M | $35.64M | $128.45M | $35.44M |
| Diluted Shares Outstanding | $297.21M | $35.64M | $128.45M | $35.44M |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Short-term Investments | $2.27M | $2.20M |
| Accounts Receivable | $26.70M | $88.24M |
| Other Current Assets | $21.23M | $20.27M |
| Total Current Assets | $854.25M | $215.73M |
| Property Plant & Equipment | $64.00M | $67.82M |
| Goodwill | $19.34M | $19.34M |
| Other Non-current Assets | $46.98M | $40.84M |
| Total Assets | $984.57M | $343.73M |
| Accounts Payable | $29.00M | $27.79M |
| Accrued Liabilities | $56.87M | $77.54M |
| Total Current Liabilities | $86.03M | $165.42M |
| Long-term Debt | $376.30M | $319.44M |
| Other Non-current Liabilities | $43.88M | $44.42M |
| Total Liabilities | $506.21M | $620.92M |
| Common Stock | $283.00K | $38.00K |
| Retained Earnings | $-2.63B | $-2.47B |
| Total Stockholders Equity | $478.36M | $-2.50B |
| Total Liabilities & Equity | $984.57M | $343.73M |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $24.32M | $-67.73M | $-150.04M | $-244.94M |
| Depreciation & Amortization | $4.90M | $10.50M | $18.32M | $39.85M |
| Stock-based Compensation | - | - | $56.64M | $13.67M |
| Change in Receivables | - | - | $-61.23M | $15.01M |
| Change in Payables | - | - | $-1.20M | $5.05M |
| Operating Cash Flow | - | - | $38.38M | $-206.28M |
| Capital Expenditure | - | - | $11.17M | $6.15M |
| Sales of Investments | - | - | - | $61.38M |
| Investing Cash Flow | - | - | $-11.17M | $55.22M |
| Stock Repurchased | - | - | $22.00K | - |
| Financing Cash Flow | - | - | $661.59M | $200.07M |
| Net Change in Cash | - | - | $688.95M | $49.01M |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.
Annual data represents full fiscal year results. FY = Fiscal Year ending.